Related Experiment Videos
Urinary cadmium and beta 2-microglobulin: normal values and concentration adjustment.
Journal of Toxicology and Environmental Health
|April 1, 1983
Summary
This study analyzed cadmium and beta 2-microglobulin levels in U.S. adult urine. Results provide benchmarks for environmental cadmium exposure, noting significant differences based on sex and age.
Area of Science:
- Environmental Health
- Toxicology
- Biochemistry
Background:
- Cadmium exposure is a public health concern.
- Establishing population benchmarks for urinary cadmium and beta 2-microglobulin is crucial for assessing environmental exposure.
- Understanding factors influencing these biomarkers is essential for accurate interpretation.
Purpose of the Study:
- To quantify the distributions of urinary cadmium and beta 2-microglobulin in the general adult U.S. population.
- To establish benchmarks for measuring the effects of environmental cadmium exposure.
- To identify practical methods for adjusting urine concentration in biomarker analysis.
Main Methods:
- Analysis of approximately 1000 urine samples from the general adult U.S. population.
- Quantification of urinary cadmium, beta 2-microglobulin, specific gravity, and creatinine levels.
- Statistical analysis to determine population distributions and correlations.
Main Results:
- Urinary cadmium levels were significantly higher in females than males and increased with age.
- Urinary beta 2-microglobulin levels were significantly higher in males than females and showed a probable relation to age.
- Urinary beta 2-microglobulin did not significantly increase with increased urinary cadmium at the levels observed.
- Urinary creatinine levels were lower in females than males and were age-dependent.
Conclusions:
- Specific gravity is the most practical parameter for adjusting urine concentration data due to its straightforward nature.
- Established benchmarks aid in evaluating environmental cadmium exposure impacts.
- Sex and age are significant factors influencing urinary cadmium and beta 2-microglobulin levels in the U.S. adult population.